Ardelyx Leaders Mike Raab & Laura Williams on Building Biotech Around Patients
Jun 10, 2026 - 00:41:21
Radio and PodcastLive Radio & Podcasts
Science & Medicine
Syndax CEO Michael Metzger on Bold Leadership, Dual Drug Launches & Redefining Cancer Care
Synopsis: Few biotechs can pull off what Syndax Pharmaceuticals has achieved — two first-in-class oncology drug launches, built entirely through strategic in-licensing and disciplined execution. In this episode, host Alo...
About This Episode
Syndax CEO Michael Metzger on Bold Leadership, Dual Drug Launches & Redefining Cancer Care is an episode from Biotech 2050 Podcast by Biotech2050 Podcast. Synopsis: Few biotechs can pull off what Syndax Pharmaceuticals has achieved — two fi...
Podcast
This episode belongs to Biotech 2050 Podcast.
Listen Online
Use the player on this page to stream the episode online.
Episode Details
Published Oct 8, 2025, 00:27:29 long, audio available.
Related Episodes
Continue listening to more episodes from Biotech 2050 Podcast.
Acadia CEO Catherine Owen Adams on Neurodegeneration, AI & Building Biotech Vision
May 13, 2026 - 00:33:34
Barry Quart, CEO of Connect Biopharma, on Asthma Innovation & Biotech Leadership
Apr 16, 2026 - 00:23:07
Adial CEO Cary Claiborne on Treating Alcohol Addiction with Genetics
Mar 6, 2026 - 00:14:16
Fred Aslan, Artiva CEO, on Cell Therapy’s Next Wave, RA Trials & Scalable NK Platforms
Feb 11, 2026 - 00:25:06
Michelle Werner, CEO of Alltrna, on tRNA Platforms, Rare Disease & Drug Innovation
Feb 10, 2026 - 00:26:40
Brian Hilberdink on Boehringer’s U.S. Growth, AI & Pharma’s Next Frontier
Jan 28, 2026 - 00:21:53